Isthmus Partners LLC Grows Stock Holdings in Henry Schein, Inc. (NASDAQ:HSIC)

Isthmus Partners LLC grew its position in Henry Schein, Inc. (NASDAQ:HSIC) by 2.8% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 9,888 shares of the company’s stock after buying an additional 266 shares during the period. Isthmus Partners LLC’s holdings in Henry Schein were worth $684,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently modified their holdings of the company. FMR LLC boosted its stake in Henry Schein by 7.8% in the third quarter. FMR LLC now owns 3,280,890 shares of the company’s stock valued at $239,177,000 after acquiring an additional 237,888 shares in the last quarter. Southpoint Capital Advisors LP lifted its holdings in shares of Henry Schein by 30.0% during the 3rd quarter. Southpoint Capital Advisors LP now owns 2,600,000 shares of the company’s stock valued at $189,540,000 after purchasing an additional 600,000 shares during the last quarter. Nuance Investments LLC boosted its position in shares of Henry Schein by 22.3% in the 3rd quarter. Nuance Investments LLC now owns 2,278,081 shares of the company’s stock worth $166,072,000 after purchasing an additional 414,748 shares in the last quarter. Clarkston Capital Partners LLC grew its stake in Henry Schein by 5.4% during the 3rd quarter. Clarkston Capital Partners LLC now owns 1,397,805 shares of the company’s stock worth $101,900,000 after buying an additional 71,560 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. increased its position in Henry Schein by 1.4% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 1,191,677 shares of the company’s stock valued at $82,464,000 after buying an additional 16,616 shares in the last quarter. Hedge funds and other institutional investors own 96.62% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently weighed in on the stock. Jefferies Financial Group boosted their price objective on shares of Henry Schein from $77.00 to $80.00 and gave the company a “hold” rating in a report on Thursday, January 23rd. Mizuho started coverage on shares of Henry Schein in a research report on Wednesday, December 4th. They set a “neutral” rating and a $75.00 price objective for the company. Wells Fargo & Company started coverage on Henry Schein in a research report on Friday, February 14th. They issued an “equal weight” rating and a $80.00 target price on the stock. Barrington Research reissued an “outperform” rating and issued a $90.00 target price on shares of Henry Schein in a research note on Wednesday, February 26th. Finally, Bank of America upgraded Henry Schein from an “underperform” rating to a “buy” rating and lifted their price target for the stock from $69.00 to $84.00 in a report on Monday, January 6th. Six investment analysts have rated the stock with a hold rating, five have assigned a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $81.10.

Henry Schein Stock Performance

HSIC opened at $74.59 on Monday. Henry Schein, Inc. has a fifty-two week low of $63.67 and a fifty-two week high of $82.49. The firm has a market cap of $9.26 billion, a PE ratio of 30.70, a P/E/G ratio of 2.13 and a beta of 0.90. The company has a quick ratio of 0.82, a current ratio of 1.42 and a debt-to-equity ratio of 0.46. The business has a fifty day simple moving average of $74.57 and a 200-day simple moving average of $72.59.

Henry Schein (NASDAQ:HSIC) last issued its quarterly earnings data on Tuesday, February 25th. The company reported $1.19 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.23 by ($0.04). The business had revenue of $3.19 billion during the quarter, compared to the consensus estimate of $3.25 billion. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The company’s revenue for the quarter was up 5.8% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.66 earnings per share. As a group, equities analysts predict that Henry Schein, Inc. will post 4.74 EPS for the current fiscal year.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.